SCRT vs ConvRT for Treatment of Benign and Low-Grade Brain Tumors

This phase 3 randomized clinical trial compares neurocognitive and endocrine functional outcomes and survival at 5 years in young patients with residual and/or progressive benign or low-grade brain tumors treated with stereotactic conformal radiotherapy or conventional radiotherapy techniques.

http://ift.tt/2rfPj1f